Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2026 Filed Jan 6, 2026 16:51 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000319 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,023.102 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 16:51 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 62 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000319 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,002.102 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 15:13 UTC |
keller brettDirector
|
GrantCommon Stock | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009848 · doc4.xml · nonDerivative · entry 1 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,654 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 15:13 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 299 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009850 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,842 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 15:13 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 149 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009851 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,136 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 15:13 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009852 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,481 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 15:13 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 160 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009849 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,940.102 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 15:21 UTC | GiftCommon Stock | 5,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009792 · doc4.xml · nonDerivative · entry 1 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,576.0271 F1 · price: The reported disposition represents a bona fide charitable gift made by the reporting person. Read SEC document |
|
| December 03, 2025 Filed Dec 4, 2025 19:02 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $148.07 | $0.00 |
DisclosureSEC source: 0001225208-25-009654 · doc4.xml · derivative · entry 7 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,548 Underlying: Common Stock · 6,000 shares Expires 2031-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 19:02 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,163 | $0.00 Strike: $93.88 | $0.00 |
DisclosureSEC source: 0001225208-25-009654 · doc4.xml · derivative · entry 6 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,163 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 19:02 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 5,548 | $229.26 | $1,271,910.62 |
DisclosureSEC source: 0001225208-25-009654 · doc4.xml · nonDerivative · entry 5 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,026 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.89 - $229.71, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 19:02 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 3,516 | $229.26 | $806,063.04 |
DisclosureSEC source: 0001225208-25-009654 · doc4.xml · nonDerivative · entry 4 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,574 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.89 - $229.71, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 19:02 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 1,150 | $229.26 | $263,644.06 |
DisclosureSEC source: 0001225208-25-009654 · doc4.xml · nonDerivative · entry 3 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,090 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.89 - $229.71, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 19:02 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionCommon Stock | 4,163 | $93.88 | $390,822.44 |
DisclosureSEC source: 0001225208-25-009654 · doc4.xml · nonDerivative · entry 2 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 19:02 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionCommon Stock | 6,000 | $148.07 | $888,420.00 |
DisclosureSEC source: 0001225208-25-009654 · doc4.xml · nonDerivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2025 Filed Nov 18, 2025 16:09 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 3,984 | $226.00 | $900,384.00 |
DisclosureSEC source: 0001225208-25-009263 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,828.521 Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:39 UTC |
Duelks Robert NDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,758 | $0.00 Strike: $225.61 | $0.00 |
DisclosureSEC source: 0001225208-25-009243 · doc4.xml · derivative · entry 5 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,758 Underlying: Common Stock · 1,758 shares Expires 2035-11-13 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:39 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 459 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009243 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,977 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:39 UTC |
FLOWERS MELVIN LDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,758 | $0.00 Strike: $225.61 | $0.00 |
DisclosureSEC source: 0001225208-25-009244 · doc4.xml · derivative · entry 2 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,758 Underlying: Common Stock · 1,758 shares Expires 2035-11-13 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:39 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 459 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009244 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,649 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:39 UTC |
keller brettDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,758 | $0.00 Strike: $225.61 | $0.00 |
DisclosureSEC source: 0001225208-25-009245 · doc4.xml · derivative · entry 2 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,758 Underlying: Common Stock · 1,758 shares Expires 2035-11-13 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:39 UTC |
keller brettDirector
|
GrantCommon Stock | 459 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009245 · doc4.xml · nonDerivative · entry 1 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,516 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:39 UTC |
MURRAY EILEEN KDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,182 | $0.00 Strike: $225.61 | $0.00 |
DisclosureSEC source: 0001225208-25-009247 · doc4.xml · derivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,182 Underlying: Common Stock · 3,182 shares Expires 2035-11-13 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:39 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 831 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009247 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,543 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:40 UTC |
Zavery AmitDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,758 | $0.00 Strike: $225.61 | $0.00 |
DisclosureSEC source: 0001225208-25-009249 · doc4.xml · derivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,758 Underlying: Common Stock · 1,758 shares Expires 2035-11-13 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:40 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 459 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009249 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,343 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:39 UTC |
Nazareth Annette L.Director
|
GrantStock Option (Right to Buy) · Derivative | 1,758 | $0.00 Strike: $225.61 | $0.00 |
DisclosureSEC source: 0001225208-25-009248 · doc4.xml · derivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,758 Underlying: Common Stock · 1,758 shares Expires 2035-11-13 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:39 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 459 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009248 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,987 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:39 UTC |
Markus Maura A.Director
|
GrantStock Option (Right to Buy) · Derivative | 1,758 | $0.00 Strike: $225.61 | $0.00 |
DisclosureSEC source: 0001225208-25-009246 · doc4.xml · derivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,758 Underlying: Common Stock · 1,758 shares Expires 2035-11-13 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 18:39 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 459 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009246 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,780.102 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008411 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,518 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008412 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,190 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
keller brettDirector
|
GrantCommon Stock | 16 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008413 · doc4.xml · nonDerivative · entry 2 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,057 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
keller brettDirector
|
GrantCommon Stock | 35 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008413 · doc4.xml · nonDerivative · entry 1 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,041 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008415 · doc4.xml · nonDerivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,712 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008415 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,705 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008417 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,884 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008417 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,870 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008416 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,528 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008416 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,519 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 19 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008414 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,321.102 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 57 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008414 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,302.102 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 14:35 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008410 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,282 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 14:25 UTC |
keller brettDirector
|
GrantCommon Stock | 121 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008099 · doc4.xml · nonDerivative · entry 1 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,006 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 14:25 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008100 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,698 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 14:25 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 140 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008103 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,245.102 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 14:25 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 121 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008102 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,853 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 14:25 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 121 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008101 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,509 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| August 25, 2025 Filed Aug 26, 2025 14:39 UTC | SaleCommon Stock | 5,674 | $258.37 | $1,466,010.10 |
DisclosureSEC source: 0001225208-25-007473 · doc4.xml · nonDerivative · entry 1 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,285.0271 F1 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person May 14, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.24 - $262.46, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
|
| August 18, 2025 Filed Aug 18, 2025 20:25 UTC | SaleCommon Stock | 5,675 | $260.87 | $1,480,427.60 |
DisclosureSEC source: 0001225208-25-007318 · doc4.xml · nonDerivative · entry 1 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 148,959.0271 F1 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person May 14, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.02 - $261.76, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.